Dupilumab Improves Patient-Reported Outcomes as Early as 1 Month among Adults with Prurigo Nodularis in Clinical Practice: Initial Results from the RELIEVE-PN Study. (2024). SKIN The Journal of Cutaneous Medicine, 8(6), s506. https://doi.org/10.25251/skin.8.supp.506